miR-146a与miR-155可作为非糖尿病及2型糖尿病牙周炎患者龈沟液的新型生物标志物
本研究检测了伴或不伴2型糖尿病的牙周炎患者及牙周健康者龈沟液中miR-146a、miR-155水平与超氧化物歧化酶(SOD)活性,发现牙周炎患者基线miR-146a和miR-155上调,非手术治疗6周后降至与牙周健康者相当水平,且miR水平与SOD活性正相关,多因素分析显示两者与牙周炎显著相关。
要点
- 牙周炎患者龈沟液miR-146a和miR-155基线表达上调,非手术治疗6周后降至健康水平。
- miR-146a和miR-155表达水平与龈沟液SOD活性呈正相关。
- 校正年龄和性别后,miR-146a和miR-155水平与牙周炎显著相关。
核心结论
- miR-146a和miR-155可能作为非糖尿病及2型糖尿病牙周炎患者的新型生物标志物。
研究设计与样本
- 采用定量实时PCR分析龈沟液中miR-146a和miR-155水平,分光光度法测定SOD活性。
- 研究对象包括伴2型糖尿病的牙周炎患者(CPDM)、不伴糖尿病的牙周炎患者(CP)、伴2型糖尿病的牙周健康者(PHDM)和不伴糖尿病的牙周健康者(PH)。
主要发现
- CP和CPDM患者基线时miR-146a和miR-155表达上调。
- 非手术治疗6周后miR-146a和miR-155水平分别降至与PH和PHDM相当的水平。
- miR-146a和miR-155表达水平与SOD活性呈正相关。
- PHDM者miR-146a水平高于PH者。
- 多因素分析显示校正年龄和性别后,miR-146a和miR-155水平与牙周炎显著相关。
临床怎么用
- 龈沟液miR-146a和miR-155或可作为牙周炎(含2型糖尿病)的辅助生物标志物,用于疾病监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: Recent studies point at the crucial role of epigenetic mechanisms in the development of multifactorial diseases such as periodontitis and diabetes mellitus (DM) type 2. In addition, circulatory microRNAs (miRs) have emerged as novel biomarkers for various diseases. Aim of this study was to investigate the levels of miR-146a and miR-155 and superoxide dismutase (SOD) activity in gingival crevicular fluid (GCF) of periodontitis patients with (CPDM) and without (CP) DM type 2 as well as in periodontally healthy, control groups (PHDM and PH, respectively). MATERIAL AND METHODS: miR modulation was analysed using quantitative real-time PCR while SOD activity was measured spectrophotometrically. RESULTS: The upregulation of miR-146a and miR-155 was observed in CP and CPDM patients' baseline, while the levels decreased after 6 weeks of the non-surgical therapy to the levels comparable to PH and PHDM, respectively. Expression levels of miRs positively correlated with SOD activity. Levels of miR-146a were higher in PHDM compared to PH patients. Multivariate analysis revealed that levels of miR-146a and miR-155 were significantly associated with periodontitis when adjusting for age and gender. CONCLUSIONS: miR-146a and miR-155 may be considered as possible novel biomarkers for periodontitis in non-diabetic and type 2 diabetic patients.
引用
- Radović N, Nikolić Jakoba N, Petrović N, et al. MicroRNA-146a and microRNA-155 as novel crevicular fluid biomarkers for periodontitis in non-diabetic and type 2 diabetic patients. J Clin Periodontol. 2018. PMID: 29517812. doi:10.1111/jcpe.12888
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。